id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-291397-look6ddt	Roberto, Palumbo	Current treatment of COVID-19 in renal patients: hope or hype?	2020-09-28		.txt	text/plain	5827	326	46	Given the lack of specific therapy about the ongoing SARS-CoV-2 infection, we conducted a brief review to summarize the mechanism of action and the potentially side effects of the treatment currently available, focusing on the effects of the drugs on renal disease at different stages in terms of therapeutic management and survival. A randomized clinical trial, handled by a Chinese group, suggested that in hospitalized adult patients with severe infection, no benefit was observed with lopinavir/ritonavir beyond standard care in terms of time to clinical improvement, reduction of mortality and safety (side effects and discontinuation of treatment) [29, 30] . Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a randomized clinical trial	./cache/cord-291397-look6ddt.txt	./txt/cord-291397-look6ddt.txt